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Abstract
Background: Among the psychological difficulties seen in children of parents with substance use
problems, the anxiety disorders are among the most chronic conditions. Although children of
alcoholic parents often struggle with the effects of parental substance use problems long into
adulthood, empirical investigations of the influence of parental substance use disorders on the
course of anxiety disorders in adult offspring are rare. The purpose of this study was to examine
prospectively the relationship between parental substance use disorders and the course of anxiety
disorders in adulthood over the course of 12 years.
Methods: Data on 618 subjects were derived from the Harvard/Brown Anxiety Research Project
(HARP), a longitudinal naturalistic investigation of the clinical course of multiple anxiety disorders.
Kaplan-Meier survival estimates were used to calculate probabilities of time to anxiety disorder
remission and relapse. Proportional hazards regressions were conducted to determine whether
the likelihood of remission and relapse for specific anxiety disorders was lower for those who had
a history of parental substance use disorders than for individuals without this parental history.
Results: Adults with a history of parental substance use disorders were significantly more likely to
be divorced and to have a high school level of education. History of parental substance use disorder
was a significant predictor of relapse of social phobia and panic disorders.
Conclusion:  These findings provide compelling evidence that adult children of parents with
substance use disorders are more likely to have relapses of social phobia and panic disorders.
Clinicians who treat adults with anxiety disorders should assess parental substance use disorders
and dependence histories. Such information may facilitate treatment planning with regards to their
patients' level of vulnerability to perceive scrutiny by others in social situations, and ability to
maintain a long-term panic-free state.
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Background
A substantial literature currently exists showing that chil-
dren from families with parental substance use disorders
are at greater risk for the development of psychiatric and
psychosocial difficulties. Children and adolescents who
have parents with substance use disorders have been
shown to be at greater risk for developing drug and alco-
hol abuse problems of their own, as well as problems with
anxiety and depression, low self-esteem, poor relation-
ships, and poor global functioning [1-7]. In adulthood,
offspring of parents with substance use disorders are gen-
erally viewed as at increased risk for lower global func-
tioning, lower educational attainment, more marital
difficulties, and greater likelihood of psychiatric disorders
than their peers with parents who do not have substance
use disorders [8-10].
Among the psychological difficulties seen in children of
parents with substance use problems, the anxiety disor-
ders are among the most chronic conditions. Prior inves-
tigations have shown the various anxiety disorders to have
a generally chronic course, with few sufferers achieving a
completely symptom free state for extended periods of
time [11-13]. To date, however, few investigations have
been conducted that directly compare the phenomenol-
ogy of the anxiety disorders among individuals who did
and did not have parents with substance abuse problems.
Based on preliminary evidence, there is reason to believe
anxiety disorder patients with parents who were substance
abusers may differ from anxiety disorder patients without
such parents. In the Epidemiological Catchment Area
(ECA) study, for example, significantly higher lifetime
rates of specific anxiety disorders were found in 407 adult
children of alcoholics compared to 1,477 matched con-
trol subjects who did not have alcoholic parents: general-
ized anxiety disorder (15% versus 8%), panic disorder
(2.7% versus 0.7%), agoraphobia (8.6% versus 4.9%),
and social phobia (3.7% versus 2%)[14]. However, the
majority of these differences were not found when com-
paring current rates of these anxiety disorders. Given the
chronicity of these disorders, it is not clear the extent to
adult children of alcoholics/addicts are more susceptible
to endure a prolonged length of time until remission from
an anxiety episode or are more vulnerable to reoccurrence
of an anxiety episode. Achieving a better understanding of
how parental substance use disorders affect the clinical
course of anxiety may aid treatment providers with diag-
nosing and treating anxiety disorders.
The few studies that have attempted to examine the rela-
tionship between parental substance use disorders and
the patterns and longitudinal course of anxiety disorders
in adulthood suffer from several noteworthy methodolog-
ical limitations. First, the great majority of studies utilize
retrospective, cross-sectional designs, with, at most, one
or two follow-up time points [4]. Such study designs do
not adequately take into account the empirically demon-
strated chronicity of anxiety disorders and are weaker than
prospective longitudinal studies. For example, if the rate
of change in anxiety symptomatology (i.e., reducing or
increasing of anxiety symptoms) is affected by having a
history of parental substance use disorders, a study with a
limited number of follow-ups would fail to capture ade-
quately such variation. Similarly, no study to date has
examined specifically the impact of parental substance use
disorders on the clinical course of one, let alone multiple
types of anxiety disorders in offspring across the lifespan
developmental stage of adulthood.
Clinical comorbidity and functional impairment have
also not sufficiently been addressed in prior studies exam-
ining the course of anxiety disorders in patients with and
without parents with substance abuse problems. Diagnos-
tic comorbidity with other anxiety disorders, major
depression, and substance use disorders is quite common
[15,16] and has been associated with a poorer course of
anxiety conditions [11,17]. Similarly, poorer general func-
tioning has been associated with a reduced probability of
remission and a greater probability of relapse for anxiety
disorders [18]. Prior longitudinal examinations have
shown that more diagnostic comorbidity and poorer psy-
chosocial functioning [12,13] are associated with a more
chronic course of anxiety symptomotology. Moreover,
patients with anxiety disorders are at increased risk for
diagnosis with multiple anxiety, depressive, and other
conditions [16]. Finally, few studies have examined other
confounding variables like childhood abuse, parental
anxiety problems, and the development of substance
abuse disorders in offspring themselves. Only one study
to date has controlled for childhood abuse. In a study of
90 families, parental alcoholism and sexual abuse were
found to be independent predictors of increased interper-
sonal anxiety among youth [19].
The goal of the present study is to examine how family
history of substance use disorders affects the clinical
course of anxiety disorders in adult offspring by providing
appropriate attention to prior methodological weak-
nesses. The current study examines the impact of parental
substance use disorders on the longitudinal course of anx-
iety disorder symptoms in the largest sample of adults cur-
rently being prospectively followed for anxiety disorders.
These examinations include the observation of multiple
types of anxiety disorders over significant lengths of time.
In addition, we utilized family history assessments that
include both parental drug and alcohol abuse/depend-
ence, and assessed the potential contribution of child-
hood abuse and parental anxiety. This study addresses
three basic questions: (1) Is the course of anxiety disorders
in adulthood impacted by a history of parental substanceSubstance Abuse Treatment, Prevention, and Policy 2007, 2:13 http://www.substanceabusepolicy.com/content/2/1/13
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use disorders? (2) What specific anxiety disorders are most
affected by parental substance use disorders? (3) How are
these patterns altered when childhood abuse, parental
history of anxiety disorders, and diagnostic comorbidity,
and functional impairment are taken into account?
Methods
This study was conducted using data from the Harvard/
Brown Anxiety Research Project (HARP), a longitudinal,
prospective, short-interval follow-up study of adults with
a current or past history of anxiety disorders. From 1989–
1991, 711 participants entered the HARP study from over
30 clinicians' practices at 11 different clinical treatment
facilities in the New England area. These methods are
described in detail elsewhere [20]. Inclusion criteria
included a past or current diagnosis of the following at
intake: panic disorder without agoraphobia (PD), panic
disorder with agoraphobia (PDA), social phobia (SP), or
generalized anxiety disorder (GAD). Insufficient for inclu-
sion, but frequently seen as comorbid conditions, were
diagnoses of simple phobia, posttraumatic stress disorder,
obsessive-compulsive disorder, or anxiety disorder not
otherwise specified. Participants must have been at least
18 years of age at intake, willing to voluntarily participate
in the study, and sign a written consent form. Exclusion
criteria consisted of the presence of an organic brain syn-
drome or a history of schizophrenia, or current psychosis
at intake. Any other comorbidity was included. Because
the focus of this study is the course of anxiety disorders,
this study excludes 5% of the 711 participants in the orig-
inal sample who were interviewed at intake only. There
were no significant differences in the distribution of anxi-
ety disorder diagnoses, illness severity, demographic char-
acteristics including gender, age of episode onset, and
clinical correlates of subjects in the study sample and
those without follow-up data.
Measures
Diagnostic assessment
The initial comprehensive evaluation assesses lifetime his-
tory using the Structured Clinical Interview for DSM-III-R
Non-Affective Disorders, Patient Version (SCID-P) and
the Research Diagnostic Criteria (RDC) Schedule for
Affective Disorders-Lifetime (SADS-L). Items on the
SCID-P and SADS-L were combined to create the SCALUP,
a structured interview used to assess diagnoses at intake
(available from M.B. Keller upon request). The instrument
yielded both present and past RDC diagnoses for affective
disorders and DSM-III-R diagnoses for nonaffective
(including anxiety) disorders. Interviews, conducted by
trained, experienced clinical interviewers whose educa-
tions ranged from B.A. to M.A., usually took place in sin-
gle sessions lasting 2 to 4 hours.
Follow-up interviews were conducted at 6-month inter-
vals for the first two years, annually for Years 3–6, and
every six months in Years 7–12. These interviews utilized
the Longitudinal Interval Follow-up Evaluation-Upjohn
(LIFE-UP, [21]), which assesses the weekly course of Axis
1 disorders with psychiatric status ratings (PSR's; Table 1).
The greatest severity of illness, a PSR 6, requires full DSM-
III-R criteria in addition to severely disrupted functioning.
A PSR of 1 indicates an absence of symptoms.
Reliability and validity studies conducted on the LIFE
found good to excellent agreement on PSR scores. Intrac-
lass correlation coefficients (ICCs) for each of the disor-
ders were as follows: 0.67–0.88 for panic disorder, 0.78–
0.86 for generalized anxiety disorder, 0.75–0.86 for social
phobia, and 0.73–0.74 for major depressive disorder [22].
Long term test-retest over one year also found very good
to excellent reliability for the anxiety disorders and for
major depressive disorder. A separate external validity
assessment comparing PSR's with other psychosocial
measures found good concurrent and discriminant valid-
ity [22].
History of parental substance use and anxiety disorders
History of parental SU and anxiety disorders were assessed
with the Family-History Research Diagnostic Criteria (FH-
RDC; [23]). The FH-RDC is an interviewer-administered
measure that assesses the history of psychiatric disorders
of immediate family members identified by the respond-
ent. For the presence of alcoholism and drug use disorder,
Table 1: Weekly Psychiatric Status Rating Scale
Code Term Criteria
6 Full Criteria, Severe Meets DSM-III-R or RDC criteria for definite criteria, severe symptoms, or extreme impairment in functioning
5 Full Criteria Meets criteria for definite symptoms but no extreme impairment in functioning
4 Marked Does not meet criteria but has major symptoms of impairment from this disorder
3 Partial Recovery Considerable less psychopathologic impairment than full criteria with no more than moderate impairment in 
functioning, but still has obvious evidence of disorder
2 Residual Either patient claims not to be completely his/her self, or rater notes presence of symptoms in this disorder in no 
more than mild degree
1 Usual Self Patient is returned to usual self without any residual symptoms of this disorder, but may have significant symptoms 
from some other condition or disorder; if so, this should be recorded under that condition or disorderSubstance Abuse Treatment, Prevention, and Policy 2007, 2:13 http://www.substanceabusepolicy.com/content/2/1/13
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the FH-RDC uses the RDC criteria for both substances.
Two criteria are required to establish the diagnosis: 1)
problem with substance use not limited to one isolated
incident and 2) at least one substance use related problem
with legal problems, health problems, marital or family
problems, work problems or impairment as housekeeper,
treatment for substance use, or social problems, such as
fights or loss of friends. The FH-RDC has been shown to
accurately reflect the psychiatric history of family mem-
bers of the respondent [24]. Interrater reliability for
chance corrected agreement (Kappa) for the diagnosis of
parental alcoholism and drug use disorders has been
shown to be excellent [25]. Test-retest interrater reliability
for specific anxiety disorders has been shown to be good-
excellent [26].
Trauma
Interviewers recorded all traumatic events reported by
subjects in response to the SCID PTSD trauma probe. Sub-
jects were asked if they experienced the traumatic events
of sexual abuse or physical abuse during childhood. The
full HARP sample fell intro three categories: those who
met full criteria for PTSD, subjects who had trauma histo-
ries but did not meet criteria for PTSD, and subjects with-
out a history of trauma. These methods are described in
detail elsewhere [27].
Definitions of remission and relapse
Remission and relapse in this study were defined prospec-
tively. Participants were considered to have recovered
from his or her anxiety disorder if he or she experienced
eight consecutive weeks at PSR ratings of 2 or less (see
Table 1). A subject who met this condition was virtually
asymptomatic for two consecutive months. This defini-
tion of remission has been widely used in studies of affec-
tive and other disorders. Relapse was defined (with the
exception of GAD) as the onset of symptoms at a PSR level
of 5 or greater for two consecutive weeks following a
remission (see Table 1). For GAD, relapse was defined as
the onset of symptoms at a PSR 5 or greater for 6 months
following a remission.
Statistical analysis
Statistical analyses were conducted using SAS version 8.0
[28], using PROC FREQ, PROC ANOVA, PROC LIFETEST,
and PROC PHREG. Depending on the type of variables
(continuous or discrete), analysis of variance (ANOVA) or
chi-square analyses were performed to evaluate demo-
graphic and clinical differences between groups. Kaplan-
Meier survival estimates were used to calculate probabili-
ties of time to remission and time to relapse of anxiety dis-
orders. Cox proportional hazards regressions were
conducted to determine whether the likelihood of remis-
sion and relapse was more adverse for subjects with a his-
tory of parental substance use disorders. Survival analysis
and cox proportional hazard regression analysis make no
assumptions about underlying survival distributions and
allow for the examination of prognostic factors when esti-
mating in time to occurrence of an event [30]. To identify
the unique value of parental SU on the course of each anx-
iety disorder, the potential confounds of childhood phys-
ical and sexual abuse, total number of comorbid anxiety
disorders, parental anxiety disorder, and the course of SU
in offspring themselves were entered into cox regression
models as covariates. Non-significant covariates (p > .50)
were removed from cox regression models using stepwise
approaches for cox regressions [30].
Results
Sample demographic and baseline clinical characteristics
Sample demographic and clinical characteristics are
described in Table 2. Study participants reported a psychi-
atric history for 580 mothers and 191 fathers. A total of
111 (18%) subjects reported a history of parental SU (92
mothers and 24 fathers). Of mothers with SU, 68%
reported alcohol abuse/dependence, 15% reported drug
abuse/dependence, and 16% reported both. These per-
centages were similar among fathers with SU: 63%
reported alcohol abuse/dependence, 20% reported drug
abuse/dependence, and 17% reported both. On average,
subjects were 17 years of age at the onset of parental SU
(M = 17.39, SD = 10.36). A total of 145 (23%) partici-
pants had a history of a parental anxiety disorder (119
mothers and 32 fathers). At intake, the HARP study sam-
ple ranged in age from 18 to 86 years (M = 41.02, SD =
12.53). Females were predominant 2:1 over males. Minor-
ities represented only 3% of the sample, reflecting the
patient populations of the recruiting sites. The majority
(53%) was married, 39% had completed college or grad-
uate school and 46% of subjects were working full-time.
In terms of clinical characteristics, 148 (24%) of the study
sample were in episode of GAD at intake, 151 (24%) SP,
311 (50%) PDA, and 72 (12%) PD. A total of 53 subjects
(9%) reported a childhood history of sexual abuse and 38
(6%) reported a childhood history of physical abuse.
As shown in Table 2, there were no significant differences
between subjects with and without parental SU in terms
of gender, status of full-time work, age, diagnostic clinical
characteristics, and childhood history of abuse. However,
subjects with parental SU were significant more likely to
be divorced (χ2 = 7.81, df= 3, p< 0.05), and to have com-
pleted only a high school level of education (χ2 = 23.60,
df= 2, p< 0.0001). Subjects with a history of parental SU
were significantly more likely to have a personal history of
SU in comparison to subjects without a history of parental
SU (χ2 = 21.45, df= 1, p < 0.0001).Substance Abuse Treatment, Prevention, and Policy 2007, 2:13 http://www.substanceabusepolicy.com/content/2/1/13
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12-year longitudinal course
Remission
With the exception of subjects with panic disorder with-
out agoraphobia (PD), a majority of subjects still main-
tained the same anxiety disorder diagnosis they had 12
years after study entry. Using Kaplan-Meier survival esti-
mates, subjects with PD were more likely to have a remis-
sion at all time points and had a 0.82 probability of
achieving remission from their intake episode of PD by
year 12. In contrast, patients with panic disorder with ago-
raphobia (PDA), generalized anxiety disorder (GAD), and
social phobia (SP) had much lower probabilities of
achieving remission over 12 years of follow-up. Patients
with GAD had a 0.58 probability of achieving remission,
while those with PDA had a 0.48 probability of recovering
from their intake episode over 12 years of follow-up.
Patients with social phobia had the least probability of
recovering after 12 years (0.37).
Relapse
Subjects who remitted from their intake anxiety disorder
had a high probability of subsequently having a relapse
over the follow-up period. Although subjects with PD
were found to have a higher likelihood of remission com-
pared to subjects with PDA, the probability of relapse was
similar (0.56 vs. 0.58 respectively). Individuals with GAD
or SP who recovered were somewhat more likely to have
a relapse over the 12 year follow-up period. The probabil-
Table 2: Demographics and Clinical Characteristics of Sample
Total
N = 618(100%)
No Parental SU1
N = 507 (82%)
Parental SU1
N = 111 (18%)
Demographic Characteristics
Female (%) 413 (67%) 338 (67%) 75 (68%)
Work full-time (%) 285 (46%) 235 (46%) 75 (68%)
Marital Status (%)
Married 328 (53%) 268 (53%) 60 (54%)
Live in Partner 32 (5%) 24 (5%) 8 (7%)
Divorced 93 (15%) 70 (14%) 23 (21%)†*
Never Partner 165 (27%) 145 (29%) 20 (18%)
Education (%)
College grad or more 243 (39%) 222 (44%) 21 (19%)†***
Partial college/HS 329 (53%) 250 (49%) 79 (71%)
Less than HS 46 (8%) 35 (7%) 11 (10%)
Age (M, SD) 41.02 (12.53) 42.89 (12.48) 40.61 (12.51)
Clinical Characteristics6
GAD2 (%) 148 (24%) 123 (24%) 25 (23%)
Age of GAD onset (M, SD) 21.50 (14.45) 21.04 (14.50) 23.80 (14.31)
SP3 (%) 151 (24%) 123 (24%) 28 (25%)
Age of SP onset (M, SD) 14.81 (8.51) 14.77 (8.72) 15.01 (7.65)
PDA5 (%) 311 (50%) 253 (41%) 58 (52%)
Age of PDA onset (M, SD) 26.93 (10.99) 26.61 (10.89) 28.31 (11.42)
PD4 (%) 72 (12%) 59 (12%) 13 (12%)
Age of PD onset (M, SD) 34.78 (12.10) 34.55 (12.09) 35.82 (12.60)
Childhood sexual abuse 53 (9%) 39 (8%) 14 (13%)
Childhood physical abuse 38 (6%) 27 (4%) 11 (10%)
1Substance Use Disorder, 2GAD = Generalized Anxiety Disorder, 3SP = Social
4PDA = Panic Disorder without Agoraphobia, 5PDA = Panic Disorder with Agoraphobia, 6Totals exceed 100% because of comorbidity
† Chi-Square test
* p < .05 *** p < .0001Substance Abuse Treatment, Prevention, and Policy 2007, 2:13 http://www.substanceabusepolicy.com/content/2/1/13
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ity of having a relapse of social phobia was 0.39, while the
probability of relapse in patients who had recovered from
GAD was 0.45 at the end of the 12 years.
Predicting anxiety course based on parental history of 
substance use disorder
Next, we used cox proportional hazard regression analyses
to evaluate whether parental SU predicted remission
from, and relapse to, GAD, SP, PD, and PDA. Demo-
graphic characteristics (gender, marital status, education,
age), childhood sexual or physical abuse, and the number
of comorbid anxiety disorders were not significant predic-
tors of the course of anxiety disorders in the study sample.
History of parental anxiety did not reach significance as a
predictor for remission or relapse of anxiety disorders. The
course of personal SU was significant only as a predictor
of GAD relapse (a full report of the non-significant find-
ings are available upon request). Thus, cox proportional
hazard regression models were reported without demo-
graphic or child abuse variables, but controlled for covari-
ates below the significance threshold of p < .50 (history of
parental anxiety, course of personal SU, anxiety disorder
comorbidity). There was no violation of the proportional
hazards assumption in cox regression models.
As shown in Table 3, history of parental SU was not a sig-
nificant predictor of remission for any of the studied anx-
iety disorders. However, history of parental SU
significantly predicted relapse in two of the studied anxi-
ety disorders: SP and PD. Results of the cox proportional
hazard regression analyses showed that individuals with a
history of parental SU were approximately four times
more likely to have a SP relapse compared to those with-
out a history of parental SU (Wald X2 = 6.27, p < .05, HR
= 4.12). Figure 1 illustrates the course of SP relapse over
12 years by those with and without a history of parental
SU. The probability of having a SP relapse was 0.74 for
adults with a history of parental SU in comparison to .47
for those with no history of parental SU. Similarly, those
with a history of parental SU were significantly more
likely to have a PD relapse (Wald X2= 5.54, p < .05, HR =
3.39). The probability of having a PD relapse was .78 for
those with a history of parental SU in comparison to .52
for those with no history of parental SU. No adults with
parental SU occurred both SP and PD relapses.
Discussion
After controlling for childhood physical and sexual abuse
as well as history of parental anxiety disorders, the course
of SU in participants themselves, and anxiety disorder
comorbidity, we found a four-fold increase in risk for the
relapse of social phobia among adults with a history of
parental substance use disorders. In contrast to the other
anxiety disorders, the onset date of social phobia was dur-
ing adolescence, and thus may be more likely to show a
stronger influence of parental behavior in adulthood.
Individuals in families with substance use disorders tend
to employ more and more isolation as a defense, mini-
mizing the amount of potential embarrassment to which
they are exposed [29]. These results suggest an important
relationship between the extent to which parents exhibit
substance abuse problems and an individual's level of vul-
nerability to perceive scrutiny by others in social situa-
tions in adulthood.
Similarly, adults with a history of parental substance use
disorders were more likely to have a PD relapse following
a period of remission. This is an interesting finding sug-
gesting that a history of parental substance use disorders
negatively impacts an adult's ability to maintain long-
term panic-free state. Moreover, it should be noted that
panic attacks, which are the hallmark feature of PD, are
complicated and variable phenomena that involve both
physical symptoms (i.e. heart palpitations, paresthesias,
chest pain) and cognitive symptoms (i.e. fear of losing
control, depersonalization), It could not be determined in
Table 3: Cox Proportional Hazard Regressions Predicting Anxiety Disorder Remission and Relapse by History of Parental SU1
Remission
Eligible Remit Chi-Square p Hazard Ratio 95% CI
SP 147 46 2.12 0.14 0.49 0.19 1.26
GAD 148 75 0.45 0.50 0.79 0.47 1.43
PDA 311 144 0.03 0.85 1.01 0.67 1.54
PD 67 47 0.32 0.57 1.25 0.58 2.66
Relapse
Eligible Relapse Chi-Square p Hazard Ratio 95% CI
SP 46 16 6.27 <.05 4.12 1.08 12.82
GAD 75 35 1.55 0.21 0.46 0.14 1.56
PDA 144 65 2.36 0.12 1.59 0.88 2.87
PD 47 20 5.54 <.05 3.39 1.23 9.38
1SU = Substance Use Disorder, 2GAD = Generalized Anxiety Disorder, 3SP = Social
4PDA = Panic Disorder without Agoraphobia, 5PDA = Panic Disorder with AgoraphobiaSubstance Abuse Treatment, Prevention, and Policy 2007, 2:13 http://www.substanceabusepolicy.com/content/2/1/13
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the current study if a history of parental substance use had
a differential effect on the variety of panic symptoms
patients experience or the frequency that certain symp-
toms recur. An interesting avenue of future research would
be to explore the differential course of specific panic
symptoms as a function of the presence or absence paren-
tal substance use disorders.
Results from this study are the first to present a lifespan
perspective of the potential impact of parental substance
use disorder on the course of anxiety disorders in adult-
hood. Like other researchers who have used similar meth-
odologies to examine psychiatric illnesses presenting in
adult children of alcoholics/addicts [7], the present study
has several methodological strengths that allow a more
extensive examination of the role of a history of parental
SU on the course of anxiety in adulthood. HARP has pro-
spectively followed a large sample of subjects with anxiety
disorders for over a decade, using comprehensive follow-
up assessments that gathered information on psychiatric
disorders in short-interval follow-ups. The naturalistic
design of this study offers a real world perspective on the
course of anxiety illness in clinical populations. In addi-
tion, HARP examines the prevalence of anxiety disorders
in general and not specifically regarding family history of
substance use disorders. Therefore, the results of the cur-
rent investigation may be less likely to be influenced by
false positives of parental substance use disorders.
This study does have some limitations that need to be
considered. First, the study uses a clinical sample that was
treatment-seeking when originally recruited. As such, the
results may not be generalizable to non-clinical and/or
non-treatment-seeking populations of anxiety patients.
Second, our assessments were also limited by a lack of
direct assessment of the status of parental substance use
disorders, relying instead on patient self-report of their
parents' behaviors. Given the tendency for children of
alcoholics/addicts to underreport parental SU, the find-
ings observed may be conservative. Third, although
approximately one-third of parents with SU had drug use
disorders, the limited number of SU parents with only
drug use disorders precluded examination of the inde-
pendent effects of parental drug use disorders. Fourth, the
number of events (remissions or relapses) limited the
number of apriori predictor variables to be tested with
adequate power in cox regression models. Future investi-
gations are warranted that examine important environ-
mental and personal characteristics that may negate or
exacerbate the effects of parental SU. Finally, the sample
was primarily Caucasian and thus generalizing our results
to non-Caucasian populations is not advisable.
Conclusion
The long-term influence of parental substance use disor-
ders on the course of anxiety disorders among children of
alcoholics/addicts and beneficial treatments specific to
these individual are potent areas for future work. An
informed clinical policy in favor of assessment of parental
substance abuse/dependence histories in the treatment of
anxiety disorders may be particularly appropriate for indi-
viduals with social phobia. These individuals may benefit
from long-term maintenance therapy that includes phar-
macological and/or non-pharmacological approaches.
The findings from this prospective longitudinal investiga-
tion highlight the importance of studies that examine the
time course of change in anxiety diagnostic status in rela-
tion to parental history of substance use disorders.
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Relapse Course of Social Phobia Disorder by History 
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